These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23041398)

  • 1. Diagnostic challenges revealed from a neuropsychiatry movement disorders clinic.
    Rigby H; Roberts-South A; Kumar H; Cortese L; Jog M
    Can J Neurol Sci; 2012 Nov; 39(6):782-8. PubMed ID: 23041398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The eye of the beholder: inter-rater agreement among experts on psychogenic jerky movement disorders.
    van der Salm SM; de Haan RJ; Cath DC; van Rootselaar AF; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):742-7. PubMed ID: 23412076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of movement disorders.
    Yung CY
    Brain Res Bull; 1983 Aug; 11(2):167-71. PubMed ID: 6627043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and applicability of movement disorder rating scales in the elderly.
    Sweet RA; DeSensi EG; Zubenko GS
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):56-60. PubMed ID: 8428136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of 49 patients with psychogenic movement disorders in a tertiary clinic in Turkey.
    Ertan S; Uluduz D; Ozekmekçi S; Kiziltan G; Ertan T; Yalçinkaya C; Ozkara C
    Mov Disord; 2009 Apr; 24(5):759-62. PubMed ID: 19205065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter and intra-rater reliability and minimal detectable difference of Movement Disorder-Childhood Rating Scale.
    Sgandurra G; Olivieri I; Casarano M; DI Pietro R; Menici V; Velli C; Sini F; Lucibello S; Romeo DM; Cioni G; Battini R
    Eur J Phys Rehabil Med; 2018 Feb; 54(1):48-57. PubMed ID: 28714297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric Treatment and Management of Psychiatric Comorbidities of Movement Disorders.
    Walsh KH; Soe K; Sarawgi S
    Semin Pediatr Neurol; 2018 Apr; 25():123-135. PubMed ID: 29735110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics of Functional Movement Disorders: A Clinic-based Study.
    Park JE
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():504. PubMed ID: 30191082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic agreement in patients with psychogenic movement disorders.
    Morgante F; Edwards MJ; Espay AJ; Fasano A; Mir P; Martino D;
    Mov Disord; 2012 Apr; 27(4):548-52. PubMed ID: 22488862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study.
    Feinstein A; Stergiopoulos V; Fine J; Lang AE
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(3):169-76. PubMed ID: 11513100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a new screening tool for neuromotor development in children aged two - the neuromotor 5 min exam 2-year-old version (N5E2).
    Aoki S; Hashimoto K; Mezawa H; Hatakenaka Y; Yasumitsu-Lovell K; Suganuma N; Ohya Y; Wilson P; Fernell E; Kamio Y; Gillberg C
    Brain Dev; 2018 Jun; 40(6):445-451. PubMed ID: 29477800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uroflowmetry with pelvic floor electromyography: inter-rater agreement on diagnosis of pediatric non-neurogenic voiding disorders.
    Faasse MA; Nosnik IP; Diaz-Saldano D; Hodgkins KS; Liu DB; Schreiber J; Yerkes EB
    J Pediatr Urol; 2015 Aug; 11(4):198.e1-6. PubMed ID: 26159493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Movement disorders is psychiatric diseases].
    Hidasi Z; Salacz P; Csibri E
    Neuropsychopharmacol Hung; 2014 Dec; 16(4):205-11. PubMed ID: 25577484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients.
    Fenton WS; Blyler CR; Wyatt RJ; McGlashan TH
    Br J Psychiatry; 1997 Sep; 171():265-8. PubMed ID: 9337982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
    Chacko RC; Root L; Marmion J; Molinari V; Adams GL
    J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movement disorders in the psychiatric patient.
    Moros DA; Yahr MD
    Hosp Community Psychiatry; 1984 Apr; 35(4):377-83. PubMed ID: 6232196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenomenology, quality of life, and predictors of reversibility in patients with drug-induced movement disorders: a prospective study.
    Anand R; Pandey S; Garg RK; Singh Malhotra H; Shrivastava S; Kar SK; Rungta S; Verma R; Kumar Sharma P; Kumar N; Uniyal R; Rizvi I
    CNS Spectr; 2023 Oct; 28(5):534-536. PubMed ID: 36529859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizures and movement disorders: phenomenology, diagnostic challenges and therapeutic approaches.
    Freitas ME; Ruiz-Lopez M; Dalmau J; Erro R; Privitera M; Andrade D; Fasano A
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):920-928. PubMed ID: 30796133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rating scale for psychogenic movement disorders: scale development and clinimetric testing.
    Hinson VK; Cubo E; Comella CL; Goetz CG; Leurgans S
    Mov Disord; 2005 Dec; 20(12):1592-7. PubMed ID: 16108025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychogenic movement disorders: frequency, clinical profile, and characteristics.
    Factor SA; Podskalny GD; Molho ES
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):406-12. PubMed ID: 7561921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.